1
Alan M Ezrin, Angelica Fleser, Martin Robitaille, Peter G Milner, Dominique P Bridon: Pulmonary delivery for bioconjugation. Conjuchem, Morrison & Foerster, March 16, 2004: US06706892 (64 worldwide citation)

Methods of and compositions for pulmonary delivery of therapeutic agents which are capable of forming covalent bonds with a site of interest or which have formed a covalent bond with a pulmonary solution protein are disclosed. Therapeutic agents useful in the invention include wound healing agents, ...


2
Dominique P Bridon, Nissab Boudjellab, Roger Léger, Martin Robitaille, Karen Thibaudeau, Julie Carette: Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders. ConjuChem, Morrison & Foerster, September 26, 2006: US07112567 (14 worldwide citation)

This invention relates to glucagon-like peptide 2 (GLP-2) derivatives. In particular this invention relates to GLP-2 peptide derivatives having an extended in vivo half-life, for the treatment or prevention of gastrointestinal disorders or diseases such as inflammatory bowel disease and other gastro ...


3
Dominique P Bridon, Robert R Dufresne, Nissab Boudjellab, Martin Robitaille, Peter G Milner: Long lasting fusion peptide inhibitors of viral infection. ConjuChem, Morrison & Foerster, August 15, 2006: US07090851 (12 worldwide citation)

Peptides exhibiting anti-viral and anti-fusogenic activity are modified to provide greater stability and improved half-life in vivo. The selected peptides include fusion inhibitors DP178 and DP107 and related peptides and analogs thereof. The modified peptides are capable of forming covalent bonds w ...


4
Dominique P Bridon, Nissab Boudjellab, Roger Léger, Martin Robitaille, Lucie Jetté, Corinne Benquet: Long lasting growth hormone releasing factor derivatives. ConjuChem Biotechnologies, Jones Day, September 11, 2007: US07268113 (11 worldwide citation)

This invention relates to growth hormone releasing factor (GRF) derivatives. In particular, this invention relates to GRF peptide derivatives having an extended in vivo half-life, for promoting the endogenous production or release of growth hormone in humans and animals.


5
John W Erickson, Dominique P Bridon, Martin Robitaille, Grant A Krafft, Dong Xie, Elena Afonina, Jun Liang, Sandra DeMeyer: Long lasting fusion peptide inhibitors for HIV infection. Conjuchem Biotechnologies, Lando & Anastasi, June 22, 2010: US07741453 (9 worldwide citation)

The present invention relates to C34 peptide derivatives that are inhibitors of viral infection and/or exhibit antifusogenic properties. In particular, this invention relates to C34 derivatives having inhibiting activity against human immunodeficiency virus (HIV), respiratory syncytial virus (RSV), ...


6
Martin Robitaille: Open clip automatic splicing system for hot melt coated tape rolls and method of using same. Martin Robitaille, Robert Brouillette, Ronald S Kosie, Gaetan Prince, September 23, 2003: US06622959 (6 worldwide citation)

An apparatus and method to auto-splice tapes in a tape dispensing machine where a continuous supply of tape is required. When a new roll of tape needs to be provided, a splicing apparatus or technique must permit to securely and efficiently make the connection between the first roll of tape and the ...


7
Dominique P Bridon, Robert P Dufresne, Nissab Boudjellab, Martin Robitaille, Peter G Milner: Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides. Conjuchem Biotechnologies, Lowrie Lando & Anastasi, September 1, 2009: US07582301 (5 worldwide citation)

Peptides exhibiting anti-viral and anti-fusogenic activity are modified to provide greater stability and improved half-life in vivo. The selected peptides include fusion inhibitors DP178 and DP107 and related peptides and analogs thereof. The modified peptides are capable of forming covalent bonds w ...


8
Dominique P Bridon, Robert S Dufresne, Nisssab Boudjellab, Martin Robitaille, Peter G Milner: Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing group. Conjuchem Biotechnologies, Lando & Anastasi, October 27, 2009: US07608271 (5 worldwide citation)

Peptides exhibiting anti-viral and anti-fusogenic activity are modified to provide greater stability and improved half-life in vivo. The selected peptides include fusion inhibitors DP178 and DP107 and related peptides and analogs thereof. The modified peptides are capable of forming covalent bonds w ...


9
Dominique P Bridon, Roger Leger, Xicai Huang, Karen Thibaudeau, Martin Robitaille, Peter G Milner: Anti-obesity agents. Conjuchem Biotechnologies, Lando & Anastasi, October 13, 2009: US07601691 (4 worldwide citation)

The present invention relates to a compound comprising a PYY peptide or a functional derivative thereof, which is coupled to a reactive group. Such a reactive group is capable of reacting on a blood component so as to form a stable covalent bond therewith. The present invention also relates to a con ...


10
Martin Robitaille, Steve Gagnon: Roll holder for tape dispenser and tape dispenser assembly therewith. Martin Robitaille, Brouillette & Partners, Robert Brouillette, Francois Cartier, October 26, 2010: US07819354 (3 worldwide citation)

The present invention discloses a roll holder for tape dispenser and a tape dispenser assembly therewith. The roll holder comprises a cylindrical body and an annular portion made from a material having a high friction coefficient, the annular portion being fixed inside the cylindrical body. The roll ...



Click the thumbnails below to visualize the patent trend.